Your browser doesn't support javascript.
loading
(5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study.
Cao, Wei; Liu, Xiaosheng; Han, Yang; Song, Xiaojing; Lu, Lianfeng; Li, Xiaodi; Lin, Ling; Sun, Lijun; Liu, An; Zhao, Hongxin; Han, Ning; Wei, Hongxia; Cheng, Jian; Zhu, Biao; Wang, Min; Li, Ying; Ma, Ping; Gao, Liying; Wang, Xicheng; Yu, Jianhua; Zhu, Ting; Routy, Jean-Pierre; Zuo, Min; Li, Taisheng.
Afiliação
  • Cao W; Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.
  • Liu X; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100730, China.
  • Han Y; Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.
  • Song X; Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing, 100084, China.
  • Lu L; Tsinghua-Peking Center for Life Sciences, Beijing, 100084, China.
  • Li X; Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.
  • Lin L; Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.
  • Sun L; Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.
  • Liu A; Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.
  • Zhao H; Department of Infectious Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, 100052, China.
  • Han N; Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, China.
  • Wei H; Beijing YouAn Hospital, Capital Medical University, Beijing, 100069, China.
  • Cheng J; Beijing DiTan Hospital, Capital Medical University, Beijing, 100015, China.
  • Zhu B; Beijing DiTan Hospital, Capital Medical University, Beijing, 100015, China.
  • Wang M; The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, Jiangsu Province, China.
  • Li Y; The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, Jiangsu Province, China.
  • Ma P; The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, Zhejiang Province, China.
  • Gao L; The First Hospital of Changsha, Changsha, 410005, Hunan Province, China.
  • Wang X; The First Hospital of Changsha, Changsha, 410005, Hunan Province, China.
  • Yu J; Tianjin Second People's Hospital, Tianjin, 300143, China.
  • Zhu T; Tianjin Second People's Hospital, Tianjin, 300143, China.
  • Routy JP; Yunnan Provincial Infectious Disease Hospital, Kunming, 650301, Yunnan Province, China.
  • Zuo M; Affiliated Hangzhou Xixi Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, Zhejiang Province, China.
  • Li T; Department of Infectious Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.
Lancet Reg Health West Pac ; 34: 100724, 2023 May.
Article em En | MEDLINE | ID: mdl-37283977

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Lancet Reg Health West Pac Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Lancet Reg Health West Pac Ano de publicação: 2023 Tipo de documento: Article